Robotic vs. laparoscopic redo ileocolonic resection for recurrent Crohn’s disease
Journal of Robotic Surgery · 2026
DOI: 10.1007/s11701-026-03300-0 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Robotic Surgery, 2026. Verfasst von Ruiqing Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Shinan District, Qingdao, 266003, China. Hauptthemen laut MEDLINE: Crohn Disease, Laparoscopy, Robotic Surgical Procedures, Ileum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Intuitive Surgical.
Abstract (Originalsprache)
Robotic surgery is increasingly utilized for primary ileocolic Crohn’s disease (CD), but its role in recurrent CD is less established. This study aimed to evaluate the feasibility and outcomes of robotic redo ileocolic resection (ICR). We retrospectively reviewed adult patients with recurrent CD who underwent either robotic (RR-ICR) or laparoscopic redo (LR-ICR) ICR at our institution between January 2020 and November 2024. Perioperative variables, conversion rate, short- and long-term postoperative outcomes were compared. Sixty-six patients were included: 24 (36.4%) underwent RR-ICR and 42 (63.6%) LR-ICR. RR-ICR was associated with a significantly lower conversion rate (4.2% vs. 23.8%, p = 0.046) and higher rate of intracorporeal anastomosis (70.8% vs. 7.1%, p < 0.001). Short-term outcomes, including morbidity (33.3% vs. 31%, p = 1), length of postoperative stay (3.6 ± 1.8 vs. 3.6 ± 2.2, days, p = 0.69), and 30-day readmission (both 16.7%, p = 1), were similar between groups. The cumulative endoscopic recurrence (ER)-free rates at 12 and 24 months were 72.1% and 51.4% in the RR-ICR group and 74.7% and 37.3% in the LR-ICR group, respectively, with no significant differences in time-to-event analysis for ER (p = 0.91) or clinical recurrence rates (p = 0.35) between the groups. On multivariable analysis, only male gender was independently associated with increased risk of ER (Hazard ratio (HR): 2.54, p = 0.028). Robotic redo ileocolic resection is a safe and feasible alternative which could offer some advantage when compared with laparoscopic surgery in patients with recurrent CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Shinan District, Qingdao, 266003, China.
- Division of Colon and Rectal Surgery, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA.
- Division of Colon and Rectal Surgery, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. Stocchi.Luca@mayo.edu.
- Division of Colon and Rectal Surgery, National Tumor Institute, Milan, Italy.
- Division of Colon and Rectal Surgery, Department of Surgery, Mayo Clinic Minnesota, Rochester, MN, 55905, USA.
Förderung
- Intuitive Surgical
Zitieren
APA
Liu, R., Stocchi, L., Sassun, R., Behm, K. T., Larson, D. W., D'Angelo, A. D., Mathis, K. L., Colibaseanu, D. T., DeLeon, M. F., Merchea, A., & Shawki, S. F. (2026). Robotic vs. laparoscopic redo ileocolonic resection for recurrent Crohn’s disease. Journal of Robotic Surgery. https://doi.org/10.1007/s11701-026-03300-0
Vancouver
Liu R, Stocchi L, Sassun R, Behm KT, Larson DW, D'Angelo AD, et al. Robotic vs. laparoscopic redo ileocolonic resection for recurrent Crohn’s disease. Journal of Robotic Surgery. 2026. doi:10.1007/s11701-026-03300-0
BibTeX
@article{Liu2026,
author = {Liu, Ruiqing and Stocchi, Luca and Sassun, Richard and Behm, Kevin T and Larson, David W and D'Angelo, Anne-Lise D and Mathis, Kellie L and Colibaseanu, Dorin T and DeLeon, Michelle F and Merchea, Amit and Shawki, Sherief F},
title = {Robotic vs. laparoscopic redo ileocolonic resection for recurrent Crohn’s disease},
journal = {Journal of Robotic Surgery},
year = {2026},
doi = {10.1007/s11701-026-03300-0}
}
EUVIMED